安科生物(300009.SZ):董事、副總裁付永標違規減持公司股份及致歉
格隆匯9月9日丨安科生物(300009.SZ)公佈,公司於2021年9月9日收到公司董事、副總裁付永標出具的《關於違規減持公司股票的情況説明及致歉聲明》,因誤操作,付永標在未預先披露減持計劃的情況下違規減持公司股票。
付永標此次減持前持有公司股份17,195,584股,佔公司總股本的1.05%。2021年9月8日,付永標在未預先披露減持計劃的情況下,通過集中競價交易方式減持公司股份5000股,佔公司總股本的0.0003%。
付永標此次減持行為未在首次賣出的十五個交易日前向深圳證券交易所報吿並預先披露減持計劃,違反了《上市公司股東、董監高減持股份的若干規定》、《深圳證券交易所上市公司股東及董事、監事、高級管理人員減持股份實施細則》等相關規定。
經公司核實,上述減持行為未發生在公司披露定期報吿的敏感期內,不存在利用內幕信息進行交易的情形。
此次違規減持行為系因其本人誤操作導致。付永標對於本次因誤操作而導致的違規交易進行了深刻反省,已深刻認識到本次違規減持事項的嚴重性及對公司造成的不良影響,主動向公司董事會進行檢討,就本次行為向公司及廣大投資者致以誠摯的歉意。並明確將加強其本人關於相關法律法規及規範性文件的學習,嚴格遵守各項法律、法規的有關規定,勤勉盡責,忠實履行自己的職責和義務,嚴格管理好個人股票賬户,杜絕類似違規行為再次發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.